Navigation Links
Bradmer provides clinical trial update and announces evaluation of strategic alternatives
Date:2/17/2009

uradiab therapy is delivered directly into the surgical resection cavity in a separate procedure after the initial surgery. Neuradiab delivers a concentrated level of radiation specifically to the remaining cancer cells by targeting tenascin. Tenascin is a protein over-expressed in 99% of GBM cells but absent from normal brain cells.

About Bradmer Pharmaceuticals Inc. (www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. Bradmer has initiated enrollment in a Phase III multi-center clinical trial of the licensed treatment. Neuradiab has been granted Orphan Drug Status by both the U.S. Food and Drug Administration and the European Medicines Agency.

Bradmer Pharmaceuticals Inc.'s common shares have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state regulatory agency in the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of Rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws.

Except for historical information, this press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, n
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
2. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
3. Bradmer announces 2008 third quarter operational and financial results
4. Bradmer to present at Rodman & Renshaw Healthcare Conference
5. Bradmer receives FDA approval to proceed with Phase III clinical trial
6. Bradmer announces 2008 first quarter operational and financial results
7. Bradmer announces new additions to management team
8. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
9. Notice of Bradmer Pharmaceuticals Conference Call
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... 29, 2015 Adults who are comparing ... nationally on the web can now use the QuotesPros.com ... quotes can now be explored while researching the automated ... Learning the differences between what a term policy provides ... challenge for some men and women. Insurers typically provide ...
(Date:3/29/2015)... 29, 2015 The culmination of one of ... when the Final Four invades Lucas Oil Stadium ... been one filled with excitement, buzzer-beaters, and of course, upsets. ... superstars have been made, and future professional products have been ... to the four teams that advanced through their regional bracket ...
(Date:3/29/2015)... NY (PRWEB) March 29, 2015 ... conduct clinical trials and research, manage data results ... help their clients reach regulation standards. Contract research ... and medical device manufacturing sectors. Industry operators provide ... early- to late-stage clinical research for Food and ...
(Date:3/29/2015)... USA (PRWEB) March 29, 2015 ... Link platform provides basic health information around ... opportunity to discuss these challenges as well as ... Health Link addresses six medical conditions using evidenced ... users to engage in conversations around them., ...
(Date:3/29/2015)... California (PRWEB) March 29, 2015 ... a new transition from Pixel Film Studios, entitled TranSports. ... transitions made exclusively for Final Cut Pro X,” said ... our users the tools needed to effortlessly transition using ... introduces TranSports, a new and uniquely styled transition pack ...
Breaking Medicine News(10 mins):Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2
... Technology Enables Pulmonx to Develop Both Assessment Tools ... May 13 Pulmonx, a medical device company ... announced today that it has acquired all of ... valve (EBV) technology platform and associated intellectual property. ...
... and Body/Facial Reshaping visualizations TORONTO, May 13 ... life-like facial and body simulations performed on ... its latest plastic surgery visualization tool, ReShapr.com.Some ... a popular online anti-aging visualization tool for ...
... healthcare company, announced today the FDA-approved guide wire-assisted ... Pathways, Inc., has been honored with the Popular ... receive another exciting external validation of this innovative ... Telesso,s CEO Nelson K. Stacks. "Attempts to start ...
... trade-offsSTANFORD, Calif., May 13 Americans want answers ... health care reform, according to new data released ... findings are the result of a unique, bipartisan ... the typically disconnected worlds of politics, academia and ...
... May 13 Zimmer Holdings, Inc. (NYSE: ZMH ... the Deutsche Bank 34th Annual Health Care Conference in Boston, ... live webcast of the presentation can be accessed via Zimmer,s ... . The webcast will be archived for replay following ...
... & Johnson (NYSE: JNJ ) will participate ... on Tuesday, May 19th, at the InterContinental Boston hotel ... for Johnson & Johnson, will represent the Company in ... will be available to interested investors and parties by ...
Cached Medicine News:Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 2Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 3Health News:ModiFace Launches ReShapr.com, the World's First Free Online Plastic Surgery Visualization Tool 2Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2
(Date:3/30/2015)... , March 30, 2015  IRIDEX Corporation (Nasdaq: ... and Trademark Office granted the Company a patent for ... suturing techniques in eye surgery. The iClip Closure Device ... to expand to a broader range of ophthalmic surgical ... a common surgical procedure used in the treatment of ...
(Date:3/30/2015)... China, March 30, 2015 China Nepstar ... the "Company"), a leading retail drugstore chain in ... stores, today announced its unaudited financial results for ... 2014. Financial HighlightsFor the quarter ended December ... by 14.2% compared to the fourth quarter of ...
(Date:3/27/2015)... CHAPEL HILL, N.C. , March 27, 2015 /PRNewswire/ ... an intimidating job description: ensure products meet quality standards ... tight budgets and escalating regulations, quality leaders also have ... costs and risk. Those who don,t effectively ... quality function as well as marketplace failure and regulatory ...
Breaking Medicine Technology:IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries 2China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 11China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 12China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 13China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 14China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 15New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTT/1P chairs are recommended for ... clean room, static control, health care ...
... chairs with concave seats and ... • Select options like seats, ... glides. • BTT/1P chairs are ... industry, education, laboratory, clean room, ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave ... lumbar support • Select options ... casters and glides. • BTT/1P ... following environments: industry, education, laboratory, ...
Medicine Products: